Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape

Purpose of Review Our review delves into the progress across urological malignancies and discusses ongoing challenges and future directions in antibody–drug conjugate (ADC) development, emphasising their transformative potential in cancer care. Recent Findings ADCs have advanced from hematologic to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current oncology reports 2024-06, Vol.26 (6), p.633-646
Hauptverfasser:	Ghose, Aruni, Lapitan, Patricia, Apte, Vedika, Ghosh, Adheesh, Kandala, Abhinav, Basu, Sreejana, Parkes, Jo, Shinde, Sayali D., Boussios, Stergios, Sharma, Anand, Das, Prantik, Vasdev, Nikhil, Rebuzzi, Sara E., Ürün, Yüksel, Kanesvaran, Ravindran, Maniam, Akash, Banna, Giuseppe L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antibodies, Monoclonal - therapeutic use Biomarkers Breast cancer Cancer therapies Chemotherapy Clinical trials Cytotoxicity Dendritic cells Drug dosages FDA approval Growth factors Humans Immunoconjugates - therapeutic use Immunoglobulins Immunotherapy Kidney cancer Kinases Malignancy Medical prognosis Medicine Medicine & Public Health Metastases Metastasis Oncology Prostate cancer Review Reviews Solid tumors Testicular cancer Topical Collection on Genitourinary Cancers Toxicity Urologic Neoplasms - drug therapy Urological cancer Urothelial cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!